Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bacillus clausii for prevention of antibiotic-associated diarrhea in children
2020-000970-10Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Jul 2020
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in antibiotic-associated diarrhea (AAD) and diarrhea comparing Bacillus clausii with Placebo (2 arms). Primary endpoint: Antibiotic-associated diarrhea occurrence. Started Jul 2020; status: terminated.
02
Drugs
bacillus clausii
03
Conditions
antibiotic-associated diarrhea (AAD)diarrhea
Beyond the preview
Go deeper on 2020-000970-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000970-10.